Biomx Inc logo

PHGE - Biomx Inc News Story

$6.36 -0.4  -5.6%

Last Trade - 16/04/21

Sector
Healthcare
Size
Small Cap
Market Cap £256.2m
Enterprise Value £215.5m
Revenue £n/a
Position in Universe 3937th / 6850

BRIEF-BiomX Presents Preclinical Results Of Phage Targeting Klebsiella Pneumoniae For Primary Sclerosing Cholangitis And Inflammatory Bowel Disease

Mon 16th November, 2020 12:32pm
Nov 16 (Reuters) - Biomx Inc  PHGE.A :
    * BIOMX PRESENTS PRECLINICAL RESULTS OF PHAGE TARGETING
KLEBSIELLA
PNEUMONIAE FOR PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY
BOWEL DISEASE
    * BIOMX INC - DETAILS SUPPORT FOR DESIGN OF PHAGE THERAPY
CANDIDATE BX003

Source text for Eikon:  ID:nBw17NtjLa 
Further company coverage:  PHGE.A 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.